Ledoxantrone

N/A

Report date: 2023/04/25 14:17:01
NME

Base Information

Drug NameLedoxantrone
Drug Alias Nameledoxantronum来多蒽醌ledoxantrone来多生琼来多蒽琼 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA replication ATP-dependent helicase/nuclease DNA2 inhibitors
TargetsDNA replication ATP-dependent helicase/nuclease DNA2
Therapy Area/IndicationsProstatic NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksKEGG